Qin Pi

Fraxinus rhynchophylla Hance

Also known as: Ash bark(English) 秦皮(Chinese)

Jinpi秦皮 진피 Ch'in P'i

Updated October 23, 2026 · Not yet clinically reviewed

Safety at a glance

Note

2 recorded drug interactions

Note

Contraindications or side effects are listed

No rule in our tables for this herb: pregnancy, breastfeeding, incompatible pairs (十八反 / 十九畏), herb–drug, dose ceiling. This is not a safety clearance.
Not graded —

No toxicity grade is recorded. Most herbs in the catalogue carry none.

Traditional Chinese Medicine

Category
clearing heat
Temperature
Cold
Taste
Bitter
Channels
Liver,Gallbladder,Large Intestine

Functions

Clears Heat and dries Dampness; Astringes the Intestines and Stops Diarrhea; Astringes to Stop Vaginal Discharge; Clears Liver Heat and Brightens the Eyes

Traditional uses

Qin Pi (秦皮) is the branch or stem bark of Fraxinus rhynchophylla Hance and related ashes (Oleaceae), Cortex Fraxini. It is bitter and astringent and cold, entering the Liver, Gallbladder and Large Intestine channels. It clears Heat and dries Dampness, astringes the Intestines to stop diarrhoea, checks abnormal vaginal discharge, and clears Liver Heat to brighten the eyes.

Its combination of cooling and astringing makes it well suited to Damp-Heat dysenteric disorders and chronic diarrhoea, and it is one of the four herbs of Bai Tou Weng Tang. It is used for Damp-Heat vaginal discharge, and — reflecting its entry into the Liver channel — for red, swollen, painful eyes and for superficial visual obstruction, where it is also applied as an eyewash.

A decoction of the bark shows a characteristic blue fluorescence, long used as a simple identity check on the drug.

Western herbalism

Properties: anti-inflammatory, antimicrobial, astringent

Pharmacological effects

  • Antibacterial: Decoction inhibited S. aureus, E. coli, Shigella flexneri and Sh. sonnei in vitro; esculin 10–20 mg/ml and esculetin (MIC 1:1000–1:2500) inhibited several bacteria.
  • Antiinflammatory: Esculin and fraxin blocked histamine capillary permeability; i.p. esculetin, esculin and fraxin reduced various induced paw edemas in rats; effect linked to adrenocortical stimulation (lowered adrenal vitamin C); esculetin/esculin reduced UV erythema in guinea pigs.
  • Sedative, anticonvulsive and analgesic: Esculin/esculetin prolonged cyclobarbital sleep in mice; esculetin antagonized electroshock and delayed strychnine/cardiazol convulsions and was analgesic (70% at 100 mg/kg i.p.).
  • Antitussive, expectorant and antiasthmatic: i.p. esculetin or esculin was antitussive in ammonia-cough mice and expectorant (phenol red); esculetin was antiasthmatic in histamine guinea pigs and relaxed isolated bronchi.
  • Lipoxygenase and cyclooxygenase inhibition: Esculetin potently inhibited platelet lipoxygenase (IC50 0.65 µM) and 5-lipoxygenase incl. in human PMNs, reducing leukotriene synthesis; also inhibited platelet cyclooxygenase (IC50 0.45 mM).

Source: Zhu YP. Chinese Materia Medica: Chemistry, Pharmacology and Applications. Harwood Academic, 1998, p. 206.

Formulas using this herb

4 of 4 formulas

Botanical

Fraxinus rhynchophylla (Chinese ash) is a deciduous tree in the Oleaceae family, growing 10-15 m tall with a broad rounded crown and grey-brown, longitudinally fissured bark on mature trunks; young branches are smooth and lenticellate. The opposite, pinnately compound leaves are 15-25 cm long with 5-7 broadly ovate to elliptic, sharply serrate leaflets, the terminal one largest, dark green above and paler beneath. The small, inconspicuous, apetalous, polygamous flowers appear in dense terminal panicles with the unfolding leaves in spring. The fruit is a slender, oblong-spatulate, single-winged samara 3-4 cm long containing one flattened seed. The medicinal Qin Pi is the dried bark of the trunk and branches, cut into curved strips or quill-like rolls with a yellow-brown outer surface (POWO; Wikipedia).

Family
Oleaceae
Pharmaceutical name
Cortex Fraxini
Parts used
bark
Plant type
tree
Native region
Hebei, Henan, Jilin, Liaoning, Shaanxi, Shanxi

Constituents

Esculin (aesculin)

Coumarin glucoside (esculetin 6-O-glucoside) · 0.26-2.80% of the dried bark across 10 commercial batches of Fraxini Cortex assayed by HPLC-UV

One of the two official quality-control markers for Fraxini Cortex in the Chinese Pharmacopoeia. Oral bioavailability is very low (reported near 0.6%); it is hydrolysed at the 8-glucose linkage to the aglycone esculetin, which is the species most likely to reach tissues. Reported activities are antioxidant, anti-inflammatory and antibacterial, and in rodent hyperuricaemia models esculin increases urinary urate and creatinine excretion.

Esculetin (aesculetin, 6,7-dihydroxycoumarin)

Simple dihydroxycoumarin aglycone · 0.11-1.47% of the dried bark across the same 10 batches of Fraxini Cortex

The aglycone of esculin and the second official marker compound; average oral bioavailability is reported around 19%, far higher than esculin. In oxonate-induced hyperuricaemic mice it lowers serum urate, and it is a lipoxygenase inhibitor with antioxidant and anti-inflammatory activity in vitro. It is a simple 6,7-dihydroxycoumarin, structurally unrelated to the 4-hydroxycoumarin anticoagulants.

Fraxin

Coumarin glucoside (fraxetin 8-O-glucoside)

Identified by bioaffinity ultrafiltration mass spectrometry as the Cortex Fraxini component that binds the urate efflux transporter ABCG2. It activated ABCG2-mediated uric acid transport in vitro with an EC50 of 7.55 micromolar and lowered serum uric acid in rats after oral dosing.

Fraxetin

Simple coumarin aglycone (7,8-dihydroxy-6-methoxycoumarin)

The aglycone of fraxin, formed by hydrolysis of the glucoside. Reported in reviews of Fraxini Cortex as contributing to the antioxidant and anti-inflammatory activity attributed to the coumarin fraction.

Drug interactions

Urate-lowering drugs (allopurinol, febuxostat, benzbromarone)

Theoretical · Possible additive lowering of serum uric acid, with a risk of over-correction or of masking the response to titrated therapy · Evidence level: Theoretical

In hyperuricaemic rat and mouse models, Fraxini Cortex extracts and their coumarins lower serum urate by more than one route: esculin and esculetin raise renal urate and creatinine excretion and up-regulate OAT1 and the OCT/OCTN transporters without changing URAT1 or GLUT9 expression, while fraxin activates ABCG2-mediated urate efflux. These are the same excretory pathways that uricosuric drugs act on. No human interaction study has been published, so the concern rests entirely on animal pharmacology.

Clinical note: If a patient on urate-lowering therapy is also taking Qin Pi, check serum urate before and after adding or stopping the herb rather than assuming the change reflects the drug dose.

Warfarin and other vitamin K antagonists

Theoretical · No anticoagulant interaction is predicted on structural grounds, but the assumption that any coumarin-containing herb thins the blood is common and can lead to unnecessary dose changes · Evidence level: Theoretical

The coumarins of Fraxini Cortex are simple 6,7- and 7,8-dihydroxycoumarins and their glucosides. They lack the 4-hydroxycoumarin substitution that is required for vitamin K epoxide reductase antagonism, and they are not 4-hydroxycoumarin dimers of the dicoumarol type, so a warfarin-like effect is not expected. Esculetin does inhibit lipoxygenase in vitro, which is the only plausible route to an effect on platelet function, and this has not been shown to translate into clinical bleeding. There are no human pharmacokinetic or pharmacodynamic interaction data for this herb with warfarin.

Clinical note: Do not adjust warfarin on the assumption of a coumarin interaction, and equally do not assume safety: if Qin Pi is started or stopped in an anticoagulated patient, check the INR as you would for any new herbal product.

Dosage

FormAmountFrequencyNotes
decoction6–12 gDaily
中国药典 2020 【用法与用量】6~12g。外用适量,煎洗患处。 【性味与归经】苦、涩,寒。归肝、胆、大肠经。 — Chinese Pharmacopoeia 2020, quoted verbatim; route and cautions preserved. Replaces a cleared category-filler value.

Dui yao: classical pairings

Qin Pi + Bai Tou Weng白头翁

Together they clear heat, dry damp, cool the blood and stop dysentery, targeting heat-toxin dysentery with blood and pus.

Core pair of a classical formula — Bai Tou Weng Tang, Shang Han Lun (Zhang Zhongjing)

Evidence

Study design on record, not certainty of outcome.

In vitro / animal
2

Research on the pharmacodynamics and mechanism of Fraxini Cortex on hyperuricemia based on the regulation of URAT1 and GLUT9

Zhou Y, Zhang X, Li C, Yuan X, Han L, Li Z, Tan X, Song J, Wang G, Jia X, Feng L, Qiao X, Liu J · Biomedicine & Pharmacotherapy · 2018 · animal

In vitro / animal · Verified

Fraxini Cortex extracts sourced from three Chinese provinces were given to rats made hyperuricaemic with hypoxanthine plus potassium oxonate. The extracts lowered serum uric acid, blood urea nitrogen and creatinine and raised urinary urate, with the size of the effect differing by geographic source, which the authors attribute to differing proportions of the coumarin constituents. The work is on the multi-species official drug Fraxini Cortex rather than on authenticated Fraxinus rhynchophylla alone.

doi:10.1016/j.biopha.2018.06.163

Target Screen of Anti-Hyperuricemia Compounds from Cortex Fraxini In Vivo Based on ABCG2 and Bioaffinity Ultrafiltration Mass Spectrometry

Huang X, Dong W, Luo X, Xu L, Wang Y · Molecules · 2023 · in vitro

In vitro / animal · Verified

Bioaffinity ultrafiltration mass spectrometry applied to plasma from rats dosed with Cortex Fraxini identified fraxin as the constituent binding ABCG2, a urate efflux transporter. Fraxin activated ABCG2-mediated uric acid transport with an EC50 of 7.55 micromolar, surface plasmon resonance gave a dissociation constant of 141.2 micromolar, and oral fraxin significantly lowered serum uric acid in rats. As above, the starting material is the official multi-species Cortex Fraxini.

doi:10.3390/molecules28237896

Safety

Contraindications

Its use is prohibited in patients with deficiency-cold of the spleen and stomach.

Source: Xi S, Gong Y. Essentials of Chinese Materia Medica and Medical Formulas. Academic Press/Elsevier, 2017, pp. 46–50.

Side effects

  • Decoction caused no side effects other than vomiting

Source: Zhu YP. Chinese Materia Medica: Chemistry, Pharmacology and Applications. Harwood Academic, 1998, p. 206.

Cultural and historical

Shen Nong Ben Cao Jing · Han dynasty

Records the bark under its older names Cen Pi and Chen Pi among the substances used for red, swollen and painful eyes and for visual obstruction, and for chronic dysenteric disorders. This is the earliest surviving Chinese record of the drug.

Ben Cao Gang Mu · Ming dynasty

Li Shizhen collates the earlier entries under the name Qin Pi and the vernacular La Shu Pi (wax tree bark), repeating the ophthalmic and dysentery indications and noting the characteristic blue fluorescence of a water soak, which is still used as an identification test.

References

  1. Zheng Z, Sun C, Zhong Y, Shi Y, Zhuang L, Liu B, Liu Z. Fraxini cortex: Progresses in phytochemistry, pharmacology and ethnomedicinal uses. Journal of Ethnopharmacology. 2024 doi:10.1016/j.jep.2024.117849
  2. Cai T, Cai B. Pharmacological activities of esculin and esculetin: A review. Medicine. 2023 doi:10.1097/MD.0000000000035306
  3. Qian ZM, Wu MQ, Tan GY, Jin LL, Li N, Xie JY. Rapid determination of aesculin and aesculetin in Fraxini Cortex by high performance liquid chromatography-ultraviolet at equal absorption wavelength. Chinese Journal of Chromatography (Se Pu). 2023 doi:10.3724/SP.J.1123.2023.03018
  4. Xin P, Fan YH, Xu JY, Mao SJ, Zhang JW, Luo ZL, Zhou X. Fraxini cortex (Qinpi): reframing a traditional heat-clearing botanical drug as a systemic immune-metabolic regulator. Frontiers in Pharmacology. 2026 doi:10.3389/fphar.2026.1799355

Look-alike names

© Verscienta Health — use subject to the API terms at https://verscienta.com/developers/api; educational reference, not medical advice